Skip to main content
Clinical Trials/NCT01198470
NCT01198470CompletedNot Applicable

A Prospective Clinical Investigation of the TRIUMPH Lumbar Disc: A Pilot Study

Globus Medical Inc1 site in 1 country20 target enrollmentStarted: September 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
1
Primary Endpoint
Number of Participants With No Device Failures

Study Overview

Brief Summary

The purpose of this investigation is to evaluate the safety and effectiveness of the TRIUMPH® Lumbar Artificial Disc for the treatment of patients who are suffering from Degenerative Disc Disease (DDD) at one level from L1 to S1.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Degenerative Disc Disease in one vertebral level between L1 and S1
  • •Able to understand and sign informed consent
  • •Had at least 6 months of conservative treatment
  • •Oswestry Disability Index Score of at least 30 (one a 100 point scale)
  • •Other inclusion criteria as specified in approved IDE protocol

Exclusion Criteria

  • •Bilateral leg pain
  • •Back or leg pain of unknown etiology
  • •Prior fusion surgery or another spinal device implanted at any other lumbar level
  • •Osteoporosis or osteopenia
  • •Other exclusion criteria as specified in approved IDE protocol

Arms & Interventions

TRIUMPH® Artificial Disc

Experimental

Treatment of degenerative disc disease with the TRIUMPH Lumbar Artificial Disc. This is a non-randomized pilot study with only one arm (no control).

Intervention: TRIUMPH® Lumbar Artificial Disc (Device)

Outcomes

Primary Outcomes

Number of Participants With No Device Failures

Time Frame: 24 months

Any device requiring surgical revision, reoperation, removal or supplemental fixation will be considered a device failure

Number of Participants Determined to Have a Normal Neurological Status

Time Frame: 24 months

Neurological status was assessed using a neurological status scale, which is based on four types of measurement parameters: motor, sensory, reflexes, and straight leg raise. The method for summarizing neurological status is described below. Each parameter (i.e. motor, sensory, reflexes, straight leg raise) is coded as follows: Motor 0 Total Paralysis 1. Palpable or Visible Contraction 2. Active Movement, Gravity Eliminated 3. Active Movement, Against Gravity 4. Active Movement, Against Some Resistance 5. Active Movement, Against Full Resistance Sensory 0 Absent 1. Impaired 2. Normal Reflexes 0 Absent or Trace 1. Hyper-reflexive 2. Normal or hypo-reflexive Straight Leg Raise 0 0° - 70° (Abnormal) 1 \> 70°-90° (Normal) If all evaluations for the parameter are determined to be normal, then the parameter is given a normal status. If any evaluations for the parameter are abnormal, then the parameter is given an abnormal status.

Number of Participants With Major Complications Defined as Major Vessel Injury or Neurological Damage

Time Frame: 24 months

Major vessel injury is defined as injury of the aorta or vena cava or other major vessels (e.g. iliac arteries, superior rectal artery, iliac veins, and their branches), caused by the surgery or device, resulting in significant blood loss or requiring additional surgery to correct. Neurological damage is defined as damage to the spinal cord or a nerve root caused by the surgery or device, resulting in neurologic deficit that persists for more than 3 months and is without improvement, is progressive, or involves motor loss. Major complications are reported on adverse event case report forms.

Number of Participants With a Change of at Least 15 Points in Pain/Disability Using the Oswestry Disability Index (ODI) Score at 24 Months Compared With the Score at Baseline

Time Frame: 24 months

The Oswestry Disability Index (ODI) is a commonly used outcome-measure questionnaire for low back pain in a hospital setting. It is a self-administered questionnaire divided into ten sections designed to assess limitations of various activities of daily living. Each section is scored on a 0-5 scale, 5 representing the greatest disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials